Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Abstract Drug repurposing is an invaluable strategy to identify new uses for existing drug therapies that overcome many of the time and financial costs associated with novel drug development. The COVID-19 pandemic has driven an unprecedented surge in the development and use of bioinformatic tools to...
Guardado en:
Autores principales: | Ali S. Imami, Robert E. McCullumsmith, Sinead M. O’Donovan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2be3084702841798028eefb4ffa0b08 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: Sinead M. O’Donovan, et al.
Publicado: (2021) -
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Steve Rodriguez, et al.
Publicado: (2021) -
Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
por: Anastasiya Belyaeva, et al.
Publicado: (2021) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Joana M. O. Santos, et al.
Publicado: (2021) -
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
por: Malina A. Bakowski, et al.
Publicado: (2021)